Northern Care Alliance Deploys Digital Pathology with Sectra

SectraThe trust's Oldham laboratory has completed technical go-live, with its Salford site also set to follow. Collectively the laboratories provide a wide range of general and specialist pathology services that support diagnoses for patients in the region. This includes one of the largest dermatology departments in the country, and gynaecology services that cover six hospitals.

Pathologists and biomedical scientists at Northern Care Alliance will become the latest in Greater Manchester to begin the process of swapping microscopes for high quality digital images. These will be seamlessly accessible through an enterprise imaging system, provided under an existing agreement in the region with medical imaging technology provider Sectra.

In total, professionals in seven laboratories across the Greater Manchester Pathology Network are due to use the enterprise imaging system, with Stockport NHS Foundation Trust being the first to deploy the pathology module earlier in 2023. The same system is already in use in acute trusts across Greater Manchester, where it is used to view and analyse radiology imaging across the region's imaging network.

Amanda Ogden, service manager for the cellular pathology and mortuary service at Northern Care Alliance NHS Foundation Trust, said: "Digital pathology is the biggest thing in decades to happen in our laboratories, and will revolutionise how we work together across former organisational boundaries to deliver services for patients, and how our clinical teams collaborate. Digital is at the top of the agenda. There is strong buy-in from our consultants who are excited by the possibilities for enhancing our diagnostics, but also for research and new discoveries.

"This will support training and improve how we share expertise. If we have an interesting case, we will no longer need to package slides and send them through the post. Instead, people across sites will have immediate access to high quality digital images. Modern ways of working will also help us to retain staff - from people starting their careers to people approaching retirement."

Historically, if a pathologist requires a second opinion, slides are sent to specialists in other hospitals to review and report. With the introduction of digital pathology, staff will have immediate access to digital images, regardless of their location. They will be able to share screens and talk through cases, learning from specialist expertise for future similar cases.

The move to digital pathology is expected to enhance multi-disciplinary team meetings and collaboration. Pathologists will be better able to work from where they need to. In some cases, this will mean that consultant pathologists will be able to work onsite with frontline clinical teams, whilst being able to collaborate with pathologists in other locations. In other circumstances, staff will be able to work from home - without the need to take slides away from the laboratory.

Matthew Goodwin, a biomedical scientist at Northern Care Alliance NHS Foundation Trust, said digital pathology would help to increase efficiency. "Until now we would spend significant amounts of time preparing slide trays for pathologists and multi-disciplinary teams, sometimes finding that the slide isn't available because it is being reviewed elsewhere," he said.

"Now images of slides will become instantly available at the click of a button to different professionals in different locations. It will mean that we can focus more of our time on quality control, ensuring that samples and stains are of the right quality before they go to be reported or discussed by pathology teams. It will allow us to collaborate more effectively around an image on a screen, allowing us to more easily and accurately review each other’s work, and to more easily train the next generation of biomedical scientists."

Jane Rendall, UK and Ireland managing director for Sectra, said: "This is the latest step in Greater Manchester's vision to break down barriers for both patients and clinical teams. It means patients having greater access to the specialists who can inform the best quality of diagnosis. And it means a collaborative clinical environment - where people can learn quickly and contribute more to effective patient care. As someone who started my career in NHS imaging, it is extremely rewarding to see such progress being made in our diagnostic services."

About Sectra

With more than 30 years of innovation and approaching 2,000 installations worldwide, Sectra is a leading global provider of imaging IT solutions that support healthcare in achieving patient-centric care. Sectra offers an enterprise imaging solution that provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Visit Sectra’s website to read more about Sectra and why it’s top-ranked in 'Best in KLAS'.

About the GM Pathology Network

The Greater Manchester Pathology Network is a collaborative pathology network across the seven GM NHS provider organisations which include:
  • Bolton NHS Foundation Trust
  • The Christie NHS Foundation Trust
  • Manchester University NHS Foundation Trust
  • Northern Care Alliance NHS Foundation Trust
  • Stockport NHS Foundation Trust
  • Tameside and Glossop Integrated Care NHS Foundation Trust
  • Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust

The network strives to deliver better patient care across clinical and diagnostic pathways and address health inequalities across the region.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...